scispace - formally typeset
T

Tomohiro Ishimaru

Researcher at University of Tsukuba

Publications -  6
Citations -  77

Tomohiro Ishimaru is an academic researcher from University of Tsukuba. The author has contributed to research in topics: Angiotensin II & Renin–angiotensin system. The author has an hindex of 6, co-authored 6 publications receiving 62 citations.

Papers
More filters
Journal ArticleDOI

Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways.

TL;DR: Clear evidence is provided that although erythropoiesis and blood pressure are negatively controlled through the AT1 receptor inhibition in vivo, the pathways involved are complex and distinct, because eriespythropoiedis is more resistant to AT1 receptors inhibition than blood pressure control.
Journal ArticleDOI

Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming.

TL;DR: It is found that histamine is elevated in the plasma of a preclinical mouse model with severe cardiac dysfunction and showed that it acts protectively rather than harmfully on heart and kidney damages in this model, and that a histamine H3 agonist, Imm, prevents the cardiorenal damages.
Journal ArticleDOI

Angiodysplasia in embryo lacking protein arginine methyltransferase 1 in vascular endothelial cells

TL;DR: Evidence is provided that PRMT1 is important for embryonic vascular formation by generating endothelial-specific prmt1-knockout mice that died before embryonic day 15, and whole-mount 3D imaging revealed dilated and segmentalized luminal structures in PrMT1-ECKO fetuses in comparison with those of controls.
Journal ArticleDOI

Lactation Is a Risk Factor of Postpartum Heart Failure in Mice with Cardiomyocyte-specific Apelin Receptor (APJ) Overexpression.

TL;DR: It is demonstrated that overexpression of APJ in cardiomyocytes has adverse effects on cardiac function in male and non-pregnant mice and that lactation contributes to the development of postpartumCardiomyopathy in the heart with APJ overeexpression.